Kana Lessig Stemsoft Software Access

As the industry moves from bench to bedside, the bottleneck often isn't the science—it’s the documentation. The Challenge of Modern Cellular Therapies

Data aggregation is only the first step. True success lies in data mining. STEMSOFT platforms, including StemLab™ and BMTserve™, allow laboratories to generate actionable insights and visualizations on the fly—without needing to be a report-writing expert. Kana Lessig Stemsoft Software

STEMSOFT provides the industry's leading cellular therapy software solutions, designed specifically to manage this complexity. By offering comprehensive informatics solutions that focus on end-to-end information management, we empower providers to: As the industry moves from bench to bedside,

STEMSOFT is a well-established division of , led by President and CEO Rob Fuller , and was founded in 1993 by Dr. Allen Eaves . Allen Eaves

By utilizing electronic batch process records (eBPR), facilities can reduce the burden of documentation, allowing researchers and clinicians to focus on producing perfect products, not just perfect paperwork. Partnering for the Long Term

The field of cellular therapy is moving at breakneck speed. CAR-T, IEC, and other advanced therapy medicinal products (ATMPs) are revolutionizing patient care, transforming how we treat cancer and other diseases. Yet, with this incredible innovation comes a complex reality: managing the data of human cells as a raw material requires unprecedented precision.